| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BB BIOTECH AG | 4.8% | -68.7% | $4,373,675 | -$9,254,867 | 2,733,547 | -67.9% | BB Biotech AG | 19 Mar 2025 |
| BlackRock, Inc. | 4.5% | $4,037,634 | 2,523,521 | BlackRock, Inc. | 31 Mar 2025 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Change | Price | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 38,780,810 | $146,973,938 | +$5,639,493 | $3.79 | 89 |
| 2025 Q2 | 38,616,493 | $95,766,554 | -$4,378,949 | $2.48 | 92 |
| 2025 Q1 | 40,656,241 | $63,017,852 | -$11,756,469 | $1.55 | 83 |
| 2024 Q4 | 47,903,925 | $102,516,125 | -$13,785,684 | $2.14 | 85 |
| 2024 Q3 | 48,717,118 | $211,892,256 | +$1,570,817 | $4.35 | 95 |
| 2024 Q2 | 46,760,739 | $217,913,327 | +$31,657,196 | $4.66 | 88 |
| 2024 Q1 | 39,430,252 | $199,910,697 | +$10,671,909 | $5.07 | 86 |
| 2023 Q4 | 38,119,952 | $107,120,051 | +$4,413,540 | $2.81 | 73 |
| 2023 Q3 | 37,180,210 | $106,709,201 | -$21,943,325 | $2.87 | 71 |
| 2023 Q2 | 41,421,828 | $209,176,335 | +$105,453,106 | $5.05 | 72 |
| 2023 Q1 | 21,491,972 | $40,617,428 | +$846,555 | $1.89 | 47 |
| 2022 Q4 | 21,053,167 | $37,894,305 | -$721,593 | $1.8 | 56 |
| 2022 Q3 | 21,487,475 | $36,340,473 | -$284,945 | $1.69 | 57 |
| 2022 Q2 | 21,498,645 | $52,895,689 | -$3,549,739 | $2.46 | 56 |
| 2022 Q1 | 22,887,182 | $64,088,307 | -$2,429,770 | $2.77 | 69 |
| 2021 Q4 | 23,198,177 | $123,630,624 | -$12,989,218 | $5.33 | 83 |
| 2021 Q3 | 24,374,413 | $206,301,397 | -$11,175,534 | $8.46 | 89 |
| 2021 Q2 | 25,397,669 | $309,589,838 | -$81,437,251 | $12.19 | 97 |
| 2021 Q1 | 29,083,953 | $705,520,847 | -$7,557,586 | $24.26 | 109 |
| 2020 Q4 | 28,616,097 | $917,170,806 | +$140,401,559 | $32.05 | 109 |
| 2020 Q3 | 23,764,080 | $718,480,421 | +$753,590 | $30.23 | 88 |
| 2020 Q2 | 22,835,597 | $959,367,654 | +$39,864,306 | $42.16 | 79 |
| 2020 Q1 | 22,285,008 | $555,219,061 | +$555,219,061 | $24.95 | 65 |